The mission of the MW CTR-IN Program is to build clinical and translational research capacity and facilitate extramural funding success, among investigators with faculty appointments at the 13 MW university partners. Our thematic focus is to address health disparities in our regions. In the past five years, the MW CTR-IN Program has provided over $6M in pilot grant funding to over 80 investigators at our partner universities.

 

MULTI-SITE PILOT PROJECTS FUNDING OPPORTUNITY

 

Final day for Submission of Nominating Packets by Institution Partners
January 22, 2020*

Invitations to investigators to submit full applications will be issued by
January 29, 2020

Application Due Date
April 15, 2020

Announcement of Applications Selected for Intent to Fund June 17, 2020

Earliest Start Date July 15, 2020**

Project Period** July 15, 2020 – June 30, 2021

* The limited competition nomination process will be determined by each institution; earlier internal
deadlines may apply.
** Actual start date will be dependent upon funding approval by NIGMS.

Pilot Grant Funding Opportunity (Multi-Site Pilot Projects): 

Please click the following LINK to download a pdf of the Multi-Site Pilot Projects (MSPPs) FOA

Purpose: The purpose of this funding opportunity is to provide support for multi-site clinical and translational (CTR) research with the expectation that the project will yield key preliminary data and capacity building to facilitate a large-scale multi-site extramural grant application or other extramural grant funding opportunities.

Overview and Criteria: Multi-Site Pilot Projects (MSPPs) must include CTR-IN partner institutions in at least three and preferably five to seven of our MW states. For example, the project will include the Lead Institution/Lead PI from one of the seven states and at least two or more and preferably >4 collaborating Site Institutions / Site Co-PIs from three and preferably five to seven of our MW states. We also recognize the complexity of conducting such a large multi-site project. Hence, potential PI and Co-PIs should consider an initial project that first demonstrates the feasibility of conducting such a large scale multi-site project. Those large scale multi-site projects that can demonstrate feasibility for the initial one year of funding are then also encouraged to apply for another year of competitive funding that builds upon the results of the first year.

Programmatic Priorities: Working in conjunction with our three Regional Community Advisory Boards (CABs) representing all seven Mountain West states, we have identified funding priorities for the communities we serve. The following themes were consistently identified across all CABs:

  • Childhood obesity and metabolic conditions including diabetes and other related factors of food security, food sovereignty, and healthy food
  • Opioid and other substance abuse, mental health / suicide prevention and psycho-social

We recognize that the above areas of research do not capture all important health priorities in all of the communities that we serve or that the CABs identified. However, we anticipate that these programmatic priorities will be revised and updated in forthcoming years as we continue to receive input from our regional stakeholders. It is also important to note that virtually most if not all of the major diseases and health conditions [e.g., cardiovascular, metabolic (e.g., diabetes), CNS, renal, etc.] are a health disparity in the Mountain West region. All applications will undergo the same scientific merit review per standard NIH procedures, regardless of the topic area.

Principal Investigator (PI) Eligibility: The PI must be eligible to submit extramural grant applications from their institution as a PI. Prior CTR-IN awardees are eligible to apply, but they must be in good standing (i.e., submission of requested progress reports and updates). Per IDeA program policy, an awardee may not concurrently receive funding for their research program through other IDeA mechanisms (e.g., CTR, COBRE or INBRE).

Direct Costs: Direct costs are $90,000 to $150,000, although justification for higher direct costs will be considered depending on the number of states and institutions involved. UNLV will administer separate subawards for each collaborating site.

Awardee Obligations: The investigator team will be expected to work with CTR-IN programmatic Cores [e.g., Professional Development, Community Engagement and Outreach, and Biostatistics, Epidemiology, Research & Design (BERD)] that will provide mentorship and guidance on multi-site clinical study design, biostatistics, community engagement and outreach, grant writing and identification of extramural funding opportunities. In particular, the investigator team should utilize support of multisite data coordination offered at the University of New Mexico – Health Science Center (UNM-HSC) through the BERD Core for funded Multi-Site Pilot Projects.

 

APPLICATION PROCESS

STEP ONE – Limited competition nomination of applicants from eligible institutions:

Applicants must be nominated by their institution and subsequently invited by MW CTR-IN Program to submit a full application. Potential applicants must contact their local MW CTR-IN Concierge and / or Vice President for Research (VPR) Office for instructions on the internal nominating process. Each partner institution may nominate up to one application as Lead Institution, but institutions can be collaborating sites on multiple proposals.

Nominating Packets must include the following for each applicant:

  • An NIH format Biographical Sketch for the proposed PI.
  • An NIH format “Other Support” document for the proposed PI.
  • A summary of the proposed research strategy of not more than two pages with sufficient detail to establish that the research is clinical or translational.
  • The list of collaborating partner sites and corresponding Site Leads.
STEP TWO – Invitation to submit pilot grant application:

Nominating Packets will undergo administrative review by MW CTR-IN Program to ensure that they are responsive to the respective funding opportunity. OSP representatives will be notified of any nominations that are found to be non-responsive. A Nominating Packet that is determined to be non-responsive may be replaced with another while the Nomination phase is open. Thus, early submission of Nominating Packets are encouraged in order to allow adequate time to prepare a replacement nominations when necessary. Applicants with approved Nominating Packets will be invited to submit a full application.

 
STEP THREE – Full application:

Detailed application instructions will be provided to applicants that are invited to submit full applications. At that time, applicants will also be provided with further guidance on obtaining biostatistical, community engagement and outreach, mentorship and other professional development support from the CTR-IN Program. With respect to preparing the research strategy and budget, the following requirements will apply:

  • Cover page – use PHS Form Page 1 (for each site)
  • Project Summary – Form Page 2 (for each site)
  • Specific Aims – 1 page
  • Research Strategy – 6 pages. Note: in addition to Significance, Innovation and Approach sections, the Research Strategy should include timeline, interim milestones, approach for coordinating across multiple sites and plans for developing and submitting a subsequent extramural grant application. Of particular importance is describing the benefit of a multi-site collaboration for achieving the team’s long-term goals. Please note that the project must include data gathering from human subjects at each site.
  • Budget details – PHS Form Page 4
    • Facilities and Administration Costs are limited to the federal/NIH de minimus rate of 10%.
    • All expenses must be allowable under NIH guidelines.
    • Travel expenses are allowed, including expenses for conducting field work as part of the project, or accessing experts or other resources such as meeting with a formal mentor. Budgets must include costs for the Lead PI to attend the CTR-IN Annual Meeting in Las Vegas. Travel expenses may be requested for the PI to present this work at one national or regional meeting, providing the meeting date is within the project period and far enough into the project for data to be available.
    • Subcontracts to institutions located in non-IDeA states are not allowable. However, services provided in non-IDeA states can be purchased on a fee-for-service basis.
  • Human Subjects – Forms E
  • IRB approval of an existing Lead Site study must be included with application if participant enrollment is planned at Collaborating Sites. If applicable, a timeline must be included for obtaining IRB approval (or reliance agreement) at Collaborating Sites.
  • Other Support for PI
  • If the PI has received prior MW CTR-IN funding, include a 1 page summary of the results of that funding. 

 

OTHER IMPORTANT INFORMATION

Eligible Mountain West Research Consortium Institutions:

  • Boise State University
  • Idaho State University
  • Montana State University
  • New Mexico State University
  • University of Alaska, Anchorage
  • University of Alaska, Fairbanks
  • University of Hawaii at Manoa
  • University of Idaho
  • University of Montana
  • University of New Mexico – Health Sciences Center 
  • University of Nevada Las Vegas
  • University of Nevada, Reno
  • University of Wyoming

The Types of Clinical or Translation Research We Fund:

Pilot projects must be clinical or translational research (CTR). Clinical research, as defined by NIH, is research with human subjects that is:

  1. patient-oriented research;
  2. epidemiological or behavioral studies; or
  3. outcomes or health services research.

Translational research has been interpreted in a variety of ways in recent years, and CTR-IN characterizes translational research according to the recent review on this topic. For this funding mechanism, we do not support pre-clinical research, sometimes referred to at T0 research. CTR-IN supports four main areas of translational research, defined as follows:

  • T1: Translation of basic science to early testing in humans;
  • T2: Early phase clinical trial; efficacy; establishment of clinical guidelines;
  • T3: Implementation and dissemination research; and
  • T4: Outcomes and effectiveness research.

The MW CTR-IN Professional Development (PD) Core:

The PD Core offers several resources to enhance your application and facilitate career advancement. For nominees, the PD Core can help identify an appropriate mentor for your project. For eventual awardees, the PD Core offers critical educational resources that are often required by NIH and that will enhance your project, such as Good Clinical Practice (GCP) and Responsible Conduct of Research (RCR) training. These resources are available to MW CTR-IN Investigators regardless of whether or not their project is selected for funding. Finally, Grant Writing Workshops (GWW) and the Advance to Funding (ATF) Program (a pre-review service offered for R-level applicants) are offered annually. We are also currently planning to potentially offer a GWW to funded Pilot Grant Awardees at the next MW CTR-IN Annual Meeting in early – June 2020 to assist in the next set of critical steps in applying for extramural grant funding. Hence, funded PG Awardees will be required to attend this important GWW.

 

CTR-IN Programmatic Resources Are Available to Assist with Application Submissions, Study Design and Career Development:

  • For questions about the nomination process, contact your institutional CTR-IN Concierge and / or VPR Office.
  • For assistance with mentorship, research training and grant writing, log into the portal (https://ctrin.health.umt.edu/public/login) and completing an intake form at Support, Create Intake Form marking the areas with which you like the Professional Development (PD) Core to assist you.
  • For assistance with study design and analysis strategy, log into the portal (https://ctrin.health.umt.edu/public/login) and completing an intake form at Support, Create Intake Form marking the areas with which you like the BERD Core to assist you.
  • For projects that involve community engagement activities, log into the portal (https://ctrin.health.umt.edu/public/login) and completing an intake form at Support, Create Intake Form marking the areas with which you like the CEO Core to assist you.
  • For questions about the portal, contact Kathrene Conway Kathrene.Conway@umontana.edu
  • For questions on the CTR-IN pilot grant program, contact Curtis Noonan curtis.noonan@umontana.edu and Scott Seville SSeville@uwyo.edu

Beth Tigges Bio

Beth Tigges, PhD, PNP, RN will serve as the Interim Director for the Tracking & Evaluation (T&E) Core of the MW CTR-IN Program. She is a tenured associate professor and Regents’ Professor at The University of New Mexico College of Nursing in Albuquerque, New Mexico. As the current Tracking & Evaluation Director of the University of New Mexico – Health Sciences Center’s (UNM-HSC) Clinical & Translational Science Center (CTSC), she is a member of leadership groups on interdisciplinary teams that seek to improve research-related infrastructure and processes and, ultimately, research productivity at organizational, regional, and national levels. Dr. Tigges received her Bachelor’s in Nursing from Penn State and went on to earn her Masters in Nursing from Yale University, and a PhD degree from Columbia University in socio-medical sciences that focused on public health and social psychology .

During an academic career that has encompassed teaching and research and spanned 33 years—Yale University (1984-87), Columbia University (1987-89), and The University of New Mexico (1989-present)— Dr. Tigges has accumulated 27 years of clinical practice in which she has served as staff nurse, school nurse, community health nurse, and pediatric nurse practitioner. Dr. Tigges’ has been and is currently funded as an investigator on numerous [U.S.] National Institutes of Health (NIH) Research Center grants that include funding for UNM-HSC CTSC, UNM Pediatric Clinical Trial Site, UNM Center for Brain Recovery and Repair, Mountain West CTR-IN Program, and National Children’s Study. As the co-chair of the Program Evaluators’ Group for the NIH Clinical and Translational Science Award Centers, her passion is to work collaboratively in research partnerships—on teams with other scientists, clinicians, and community members.

Robert Seville Bio

Robert “Scott” Seville, PhD, will serve as the Associate Director of the MW CTR-IN Pilot Projects (CP3) Core and is the Chair of the Concierge Network. He is currently a Professor of Zoology and Physiology in the College of Arts and Sciences at the University of Wyoming. Currently, he serves as the Lead Concierge for MW CTR-IN Concierge Network. Previously, he served as the Associate Dean for the University of Wyoming Outreach School where he had oversight of UW facilities, staff and programs across Wyoming including managing UW Academic Regional Centers located on each Wyoming community college and the Wind River Indian Reservation. He received his Master’s and PhD degrees, and Postdoctoral training in Zoology/Physiology/Parasitology from the University of Wyoming, Laramie, in Wyoming followed by a NSF/NATO Fellowship in Parasitology.

Dr. Seville’s research has focused on the taxonomy, systematics, and parasite-host co-evolution using gastrointestinal protozoan parasites (coccidia) in wild hosts as a model system. Additionally, he brings experience in leading and managing NIH-funded activities as the Program Director/Principal Investigator, Outreach/Education Core Director, and previously Program Coordinator for the IDeA-funded Wyoming INBRE program. In these leadership roles, he has been responsible for working with the INBRE leadership team and the University of Wyoming Office of Research and Economic Development in managing ~$35M in support from NIGMS IDeA Programs with a number of research, education programs and projects focused on addressing health disparities in rural and American Indian communities in Wyoming.

Tony Ward Bio

Tony Ward, PhD, will serve as the Director for the new upcoming Community Engagement and Outreach (CEO) Core in Years 6-10 of the MW CTR-IN Program. In addition to teaching within University of Montana’s School of Public and Community Health Sciences, Dr. Ward’s research focuses on investigating the relationship between air pollution and respiratory health, working with rural and American Indian (AI) and Alaska Native (AN) populations throughout our region. Concurrently, he is the Co-PI on two NIEHS-funded R01s investigating the impact of residential wood burning on respiratory health in both children and elderly populations living in rural and tribal areas located in the southwest, northern Rocky Mountains, and rural Alaska Native communities. He is also the Co-PI on a NIH funded Science Education Partnership Award (SEPA) project that educates rural and AI/AN students in schools throughout Montana, Idaho, and Alaska about air quality/respiratory health. Moreover, Dr. Ward is the Chair at the University of Montana, School of Public and Community Health Sciences in Missoula, Montana, and the State of Montana Director of the CEO Core for the AI/AN Clinical Translational Research Project (CTRP). Dr. Ward received his Masters degree in Environmental Science and Industrial Hygiene from the University of Houston, Clear Lake in Texas, and his PhD degree in Environmental Chemistry from the University of Montana, Missoula, in Montana along with a Postdoctoral.

Dr. Ward has experience conducting Community Based Participatory Research (CBPR) in rural and underserved communities, including AI/AN communities. His experience with the AI/AN CTRP will be a valuable asset for his role as the CEO Core Director for the CTR-IN, providing synergy for both of the IDeA Programs.

Melissa Ann Schiff Bio

Melissa Ann Schiff, MD, MPH is the Associate Director of the MW CTR-IN BERD Core. Dr. Schiff is also a Research Professor for the Department of Internal Medicine, Division of Epidemiology, Biostatistics and Preventative Medicine at the University of New Mexico’s School of Medicine. She received her Bachelor’s Degree in Psychology and MD Degree from the University of Michigan. She completed her Obstetrics & Gynecology residency at the University of New Mexico and went on to complete her Masters in Public Health with an emphasis in Epidemiology at the University of Washington.

Dr. Schiff has over 30 years of experience as an epidemiologist including extensive experience focusing on the areas of maternal and child health as well as injury epidemiology and prevention. She has been involved in research, teaching and mentoring which also includes experience in the design and analysis of epidemiologic studies both as a principal investigator and as an advisor/mentor for public health students, medical students, residents and faculty. Dr. Schiff has also served as the Director of the Center of Excellence in Maternal and Child Health, A HRSA-funded training program for public health MPH graduate students at the University of Washington. She has also developed and taught a Summer Institute course to train public health professionals in basic epidemiology and is currently teaching medical students the University of New Mexico epidemiology and biostatistics. Her unique background is integral to the BERD Core as she assists its director in developing education and training for the MW CTR-IN network investigators.     

Ruben Dagda Bio

Ruben Dagda, PhD, is the Associate Director of the Professional Development (PD) Core for the MW CTR-IN Program. In this role, he coordinates the Advance to Funding (ATF) Program and the Grant Writing Workshops (GWW). He received his PhD degree in Pharmacology from the University of Iowa and received his Postdoctoral training at the University of Pittsburgh School of Medicine. Dr. Dagda is also an Associate Professor of Pharmacology at the University of Nevada Reno

In this role for the ATF Program, he assists research investigators in the review of their grants prior to submission to the NIH to provide constructive feedback from our many expert reviewers to increase their probability of extramural funding. Hence, the ATF Program functions very much like a “study section”. He is also in charge of coordinating the GWWs, which assist research investigators in improving their knowledge and skills in the preparation of grants to make them more competitive for extramural grant funding. He is currently investigating the molecular mechanisms that lead to mitochondrial dysfunction and oxidative stress in cell culture, tissue and animal models of Parkinson’s disease. Dr. Dagda has authored multiple research manuscripts and review articles in the areas of toxicology, toxinology, mitochondrial function, and neurobiology. At the University of Nevada Medical School (UNSOM), he is committed to the training and education of undergraduate, graduate students and postdocs in his lab. His main research goals are to elucidate the prosurvival signaling pathways that regulate mitochondrial function, transport and turn-over in neurons and how aging and neurodegenerative diseases negatively impact these processes. The end goal is to develop novel small molecular drugs that can reverse neurodegeneration and elevate mitochondrial function in age-related neurodegenerative diseases.

Merle Kataoka-Yahiro Bio

Merle Kataoka-Yahiro, DrPH, MS, APRN is an Associate Director of the Professional Development (PD) Core of the MW CTR-IN Program since 2013. She coordinates the Education/Training for the PDC. She is a Professor in the School of Nursing and Dental Hygiene at the University of Hawaii at Manoa. Additionally, she has served as PI for the NIH Extramural Associates Research Development (EARDA) Awards, Office of Research Development in 2013, and served as the Section Leader and Co-Leader for the Research Centers in Minority Institutions (RCMI) Multidisciplinary and Translational Research Infrastructure Expansion Hawaii Grant (RMATRIX) from 2010 – 2014. Dr. Kataoka-Yahiro earned two Master’s degrees in Parent-Child Nursing (Rush University) and Public Health (Northwestern University) and a DrPH in Public Health from the University of Illinois, School of Public Health in Chicago, Illinois.

Dr. Kataoka-Yahiro’s research area has been in health disparities research focused on chronic disease management with vulnerable populations which include women, children, older adults, and minority populations. Currently, she is examining and analyzing population data sets of Asian Pacific Islander and Native Hawaiian groups and chronic diseases, specifically in prevention of chronic kidney disease (CKD) and associated cardiovascular risk factors (diabetes, hypertension, and obesity). Dr. Kataoka-Yahiro has mentored a cadre of diverse faculty and students through developing and providing scientific research training opportunities targeting towards health disparities research in clinical translational research.

Yiliang Zhu Bio

Yiliang Zhu, PhD, is the Director of the Biostatistics, Epidemiology and Research Design (BERD) core for the MW-CTR-IN Program. He is also a Professor in the Division of Epidemiology and Biostatistics in the Department of Internal Medicine at the College of Medicine at the University of New Mexico HSC. He received his Masters and PhD degree in Statistics from Queen’s University, Kingston and University of Toronto, Toronto, Canada.

Dr. Zhu’s expertise is in data analytics. His recent research has focused on health system and policy, health outcome evaluation, and data analytic methods. In the Loess Plateau Health Project (2013-2030) in northwestern rural China, he established a multidisciplinary, international team during his Fulbright Fellowship (2012-13) during which he and his team conducted observational and interventional studies on healthcare system development, policy assessment, health promotion, as well as health disparities within the content of the local environment and rural development. Additionally, he has actively conducted research in statistics methods, focusing on spatially and temporally clustered data and applications in health risk assessment. More recently, he has studied integrative system modeling as informed by biological mechanisms to seek ways to integrate data across heterogeneous systems. He has over 20 years of collaborative experiences in health and clinical and translational research, as well as experience in leading biostatistics research support in academic settings. He is committed to integrating biostatistics support into the fabric of MW CTR-IN clinical and translational research culture.

Mark R. Burge Bio

Mark R. Burge, MD,

Mark Burge, MD is the Core Director of the Professional Development (PD) Core for the MW CTR-IN Program. He received his Bachelor’s Degree in Biology from the University of Oregon and an MD degree from Oregon Health Sciences University. He completed his Internal Medicine residency at the University of Wisconsin, Madison and is an Endocrinology Fellow at the University of New Mexico.

Dr. Burge is an established clinical and translational investigator in Diabetes at the University of New Mexico (UNM) – Health Science Center (HSC). He was a Co-Investigator in two of New Mexico’s landmark clinical trials in Diabetes which include the Diabetes Control and Complications Trial (DCCT) as well as the Diabetes Prevention Program (DPP).  Dr. Burge also served as a Principal Investigator for one of the NIH-funded, investigator-initiated studies focused on the characterization of the pathophysiology of hypoglycemia in type 2 Diabetes, and has also contributed to science with his work as the Principal Investigator on several studies aimed at the novel application of technology to the evaluation and care of patients with Diabetes Mellitus. 

Dr. Burge has been involved in leadership roles, serving as the longstanding Program Director for the UNM General Clinical Research Center (GCRC) and currently serves as the Deputy Director of UNM’s   Clinical and Translational Science Center (CTSC). He has also served as Councilor and President for the Western Region of the American Federation for Medical Research, the National Office of the American Federation for Medical Research, and the Western Society for Clinical Investigation. He has continued as the leader of the HUB Research Capacity and Network Capacity sections to administer the Pilot Award Program and to Chair the Sage Committee, which reviews pilot awards. As a current member of the Board of Directors of the Association for Clinical and Translational Science (ACTS), he is passionate about the transformative potential and importance of scientifically sound clinical and translational research.

Larissa Myaskovsky  Bio

Larissa Myaskovsky, PhD, is the Associate Director of the Professional Development (PD) Core for the MW CTR-IN Program. As the Associate Director for the PD Core, Dr. Myaskovsky’s focus is on the Mentorship Program.  Dr. Myaskovsky received her B.A. degree in Psychology with Specialization in Women’s Studies from the University of California, Los Angeles, Master’s in General-Experimental Psychology from California State University, Northridge. She attained her PhD in Social Psychology from the University of Pittsburgh and completed her Post-Doc in Clinical Epidemiology at the University of Pittsburgh, School of Medicine. 

Dr. Myaskovsky is the Director of the Center Healthcare Equity in Kidney Disease at the UNM Health Sciences Center, and the Chief of the Division of Epidemiology, Biostatistics and Preventive Medicine in the Department of Internal Medicine at UNM School of Medicine. With over 20 years of research experience and funding, she is well-qualified to serve as the Associate Director for the Professional Development Core under Mark Burge. Her NIH and VA-funded research focuses on the social determinants of health and using a multi-method and multi-disciplinary approach to identify and understand disparities in healthcare processes and outcomes, and to develop interventions to reduce health disparities in people with disabilities, chronic conditions, and end-stage kidney disease. She has multidisciplinary training in social psychology and clinical epidemiology, and has pursued a research career focused on bringing social and behavioral science to bear on the field of health services research. Before joining the faculty of UNM HSC in 2017, she was a tenured Associate Professor of Medicine, Psychiatry, and Clinical and Translational Science at the University of Pittsburgh, School of Medicine and a Research Health Scientist at the Center for Health Equity Research and Promotion (CHERP) and the Veterans Engineering Resource Center (VERC) at the VA Pittsburgh Healthcare System.  She taught medical writing and presentation, research grant design and development, measurement design and development, and healthcare disparities research methods to early career faculty, fellows, graduate and medical students. She also successfully mentored the research of undergraduates, graduate and medical students, residents, fellows, and faculty. In her final year at the University of Pittsburgh, she completed a year-long NIH-funded Professional Mentoring Skills Enhancing Diversity (PROMISED) leadership training program through the National Research Mentoring Network, and was the 2017 recipient of the Philip Troen, MD Excellence in Medical Student Research Mentoring Award, presented by the University of Pittsburgh, School of Medicine.

She has a natural passion for research education, supporting scholars, and trainees as they learn the steps necessary to assemble an independent research program. Her mentoring experience provides a strong basis for his leadership for the MW CTR-IN Program’s PD Core.

Curtis Noonan Bio

Curtis Noonan, MA, PhD, is the Director of the MW CTR-IN Pilot Projects Program (CP3) Core. He has served in this role for the past five years and will continue to serve in this role for the next grant cycle. The Pilot Projects Program has successfully administered the single institution, single investigator and the multi-site pilot grants since the inception of the MW CTR-IN Program.

Dr. Noonan received his MA degree in International Health and Development from George Washington University and his PhD in Environmental Health, Epidemiology from Colorado State University. He is currently a Professor of Epidemiology in the College of Health Professions and Biomedical Sciences at the University of Montana. He has led NIH funded multi-site randomized trials focused on improving health outcomes and reducing exposures among vulnerable populations exposed to elevated levels of particulate matter from burning of biomass fuels for residential heating. Dr. Noon is a member of the Infectious, Reproductive, Asthma and Pulmonary Conditions (IRAP) Study Section.

Carl Reiber Bio

Carl Reiber, PhD, has served as the MW CTR-IN Program Deputy Director since 2013. He is also the Senior Vice Provost and a Professor in the School of Life Sciences at the University of Nevada, Las Vegas in the College of Sciences. Additionally, he has been the Program Coordinator of the NV INBRE since 2008, and the Steering Committee Lead since 2017. Previously, he was the cluster leader in two statewide NSF EPSCoR grants ($6M) and functioned as the coordinator for an NIH Bridges grant. He also served as an ad hoc and permanent member of several NSF review panels including mentoring numerous undergraduate and graduate students (MS and PhD). Dr. Reiber received his Masters degree in Cell Biology from George Mason University, Fairfax in Virginia and PhD degree in Zoology-Physiology from the University of Massachusetts in Amherst Massachusetts followed by Postdoctoral training from the University of Florida, Gainesville, Florida.

Richard Larson Bio

Richard Larson, MD, PhD, serves as the CTSC Liaison for the MW CTR-IN Program. He is the Executive Vice Chancellor for Research of Health Sciences at the University of New Mexico Health Sciences Center as well as a tenured Professor at the University of New Mexico. In addition, he is also the PI of the UNM Clinical and Translational Science Center. He also served on the Board of Directors for the National Center for Genome Research. In 2001, he co-founded Cancer Services of New Mexico, a non-profit organization which serves, free of charge, over 2000 New Mexicans suffering from cancer each year. Moreover, he is the President of the Cancer Services of New Mexico Foundation. In addition, Moreover, he also serves as the Chair of the Mountain West Research Consortium, which was critical in laying down the ground work for the eventual development of the MW CTR-IN Program. Dr. Larson received his MD and PhD degrees from Harvard University and performed his residency training at Washington University in St. Louis and fellowship training at Vanderbilt University in Pathology.

Parvesh Kumar Bio

Parvesh Kumar, MD, is the Principal Investigator (PI) of the MW CTR-IN Program. In addition, he also, serves as the Vice Dean of Research for the UNLV School of Medicine. Dr. Kumar received his B.Sc. degree (with honors) in Chemical Engineering from the University of Kansas in 1981 and his M.D. degree from the University of Kansas School of Medicine in 1986. He completed his residency training in Radiation Oncology at Thomas Jefferson University Hospital in 1990, while also serving as Chief Resident and Fellow of the American Cancer Society during his senior year.

Dr. Kumar is an experienced clinical and translational researcher who has led several multi-institutional, multi-disciplinary national oncology clinical trials sponsored by the NCI [i.e., Cancer & Leukemia Group B (CALGB) Protocols 8935 and 9134 in Non-Small Cell Lung Cancer and CALGB Protocol 9493 in Prostate Cancer, and Radiation Therapy Oncology Group Protocol Protocol 9615 in Head & Neck Cancer]. In addition, he has also conducted several other federal (i.e., Department of Defense) and pharma (i.e., Aventis Oncology) funded investigator initiated clinical trials. Moreover, his leadership experiences include building and managing research programs as Chair of the Departments of Radiation Oncology at 4 major medical schools and at several NCI-designated Cancer Centers. In his several research leadership roles, he has developed significant experience in health disparity research. For example, as Associate Director of Clinical Research for the University of Kansas Cancer Center, ensuring appropriate enrollment of under represented patient populations to therapeutic clinical trials was a critical requirement for the NCI and an important objective of his leadership role.

Xiaomeng (Mona) Xu

Dr. Xu is a 2015 MW CTR-IN Pilot Grant Awardee recipient. Her project was entitled, “Understanding the Role of Self-Expansion in Physical Activity”. Her research focuses on cardiovascular behavioral health including weight control, smoking and physical activity; close relationships, especially romantic; and magnetic resonance imaging (MRI) neuroimaging. Dr. Xu is also interested in these research areas in the context of individual differences such as trait self-control, and development over time, such as aging or as a romantic relationship progresses.

Dr. Xu received a Bachelor of Arts Degree in psychology from New York University, and Master of Arts Degree in psychology from Stony Brook University, and a Ph.D. in social health psychology from Stony Brook University. She completed a postdoctoral research fellowship sponsored by the National Institutes of Health at The Warren Alpert Medical School of Brown University and The Miriam Hospital.

Dr. Xu is an Assistant Professor of Experimental Psychology at Idaho State University and was honored as a 2015 Rising Star from the Association for Psychological Science. As a result of her advanced work in the field, the Association for Psychological Science has recognized Dr. Xu as an outstanding psychological scientist. As facilitated by the Individualized Development Plan (IDP) which is a critical component of the CTR-IN PG award, Dr. Xu had a successful mentorship experience with her mentor, Claudio Nigg, PhD, from the University of Hawaii. The pilot grant’s IDP provides mentorship for career development. As a result of the mentoring facilitated by the IDP, Dr. Xu has collaborated with Dr. Nigg on various projects, which have led to a manuscript publication, poster presentations, future collaborations, etc. Moreover, based on her academic productivity which has been significantly facilitated by the MW CTR-IN PG award, she will be applying for tenure at Idaho State University.

Susan Tavernier

Education: BSN from Whitworth University in Spokane in Washington; MSN from Loyola University of Chicago; PhD in Nursing from the University of Utah; Postdoctoral fellowship from the College of Nursing at the University of Utah.

MW CTR-IN helped to provide education in grant management, post-award processes, timeline projections, and meaningful tools for grant tracking.

Dr. Tavernier was a Year 4 MW CTR-IN Pilot Grant Awardee in 2016. Her project was entitled, “The Patient Voice in Healthcare”. The MW CTR-IN pilot grant was also instrumental in helping her with the nuances of grant management including hiring personnel, budgets, quarterly and annual reports. As a nurse scientist, her research area focuses on cancer patients. She has gained expertise with large qualitative data sets and has conducted research in the clinical setting. Dr. Tavernier is currently an Assistant Professor at Idaho State University in the School of Nursing and was a recipient of a Presidential Scholarship for new health service researchers from Academy Health.
Additionally, she has authored a chapter on Symptom Distress in the textbook Cancer Symptom Management 4th Edition, and has served as a review panel member for the Oncology Nursing Foundation for research and awards. She is also an active member of the Oncology Nursing Society.

Blakely Brown

Education: PhD in Nutritional Biochemistry from the University of Minnesota; RD from the University of Minnesota

MW CTR-IN helped to expand collaborations for a nutrition and physical activity study with a direct impact on the health of community children.

Dr. Blakely Brown was a MW CTR-IN Pilot Grant (PG) Awardee and Visiting Scholar in 2014. Her project was entitled, “Developing and Pilot Testing Parent Education Activities within a Childhood Obesity Prevention After-School Program”. Dr. Brown built upon this PG research funding from the MW CTR-IN Program and secured 3 additional extramural grants also in the areas of childhood obesity totaling $278,167 in extramural grant funding as follows: (1) Partnerships to Prevent Childhood Obesity on the Flathead Indian Reservation; (2) Generations Health Project: An After-School and Home Based Childhood Obesity Prevention Program; (3) and USDA Strengthening Grant: Growing Strong Generations. These research studies have allowed Dr. Brown to successfully expand her research collaborations with rural and Native American communities that have resulted in longitudinal outcomes reporting risk factors for diabetes in native and non-native children, assessments of environmental and behavioral factors associated with risk for childhood obesity and diabetes in youth in rural communities.
Dr. Brown’s research, teaching and service focus on nutrition and chronic disease prevention, maternal-child health, childhood obesity and diabetes prevention, community-based participatory research methods, Native American health and diversity-related activities.